drchrono releases API for developers

Article

Drchrono, Inc. recently launched its application programming interface (API) that will allow developers to build their own healthcare applications.

Mountain View, CA-Drchrono, Inc., the creator of a free electronic medical record (EMR) platform on the iPad, iPhone, and cloud, recently released its application programming interface (API)
 that will allow developers to build their own healthcare applications on top of the drchrono platform.

Only 1.3% of APIs listed on ProgrammableWeb, an API database, are associated with the medical services sector. Innovators have avoided developing applications for the healthcare industry due to high regulations and the difficulty in accessing APIs from health institutions. Drchrono wants to ease developers’ requests to the API as easy as a sign-up and one-week review process. Drchrono would like to encourage developers to find opportunities in the evolving healthcare space to launch new companies. The current procedure for accessing a health institution’s API involves working with the organization’s business development team, a potentially lengthy process. Because each institution uses its own API, it can be a very time consuming process for companies to access it. By leveraging drchrono, these organizations can access their patients’ information for application construction within a week. 

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Susana Marcos, PhD, discusses the implications her research presents for the role optical coherence tomography (OCT) could play in presbyopia and myopia accommodation efforts.
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
© 2025 MJH Life Sciences

All rights reserved.